| Norton Healthcare

A Multicenter Platform Trial of Putative Therapeutics for the Treatment of COVID-19 in Hospitalized Adults

Sub-indication: COVID-19 Infection

Drug Study

Principal Investigator: Paul Schulz, M.D.
Norton Infectious Diseases Institute

Sponsor: National Institute of Allergy & Infectious Disease

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.